IFRX
(NASDAQ)InflaRx N.V.
$1.80-- (--)
Loading... - Market loading
InflaRx (IFRX) Stock Price & Financial Analysis
InflaRx Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$1.77 - $1.87
52-Week High$2.95
52-Week Low$0.74
Open$1.85
Volume1.03M
Average Volume (3M)1.29M
Market Cap130.85M
Shares Outstanding72.29M
Price to Sales (P/S)4115.78
Price to Book (P/B)3.27
EV/EBITDA-2.60
Revenue (TTM)33.46K
Net Income (TTM)-48.95M
Free Cash Flow (TTM)-33.09M
EPS (TTM)$-0.71
Profit Margin-146304.01%
Operating Margin-144761.49%
Return on Equity (ROE)-116.20%
Debt to Equity0.02
50-Day MA$2.14
200-Day MA$1.40
52-Week Change120.07%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$1.77 - $1.87
52-Week High$2.95
52-Week Low$0.74
Open$1.85
Volume1.03M
Average Volume (3M)1.29M
Market Cap130.85M
Shares Outstanding72.29M
Price to Sales (P/S)4115.78
Price to Book (P/B)3.27
EV/EBITDA-2.60
Revenue (TTM)33.46K
Net Income (TTM)-48.95M
Free Cash Flow (TTM)-33.09M
EPS (TTM)$-0.71
Profit Margin-146304.01%
Operating Margin-144761.49%
Return on Equity (ROE)-116.20%
Debt to Equity0.02
50-Day MA$2.14
200-Day MA$1.40
52-Week Change120.07%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About InflaRx
What is the current stock price for IFRX?
As of the latest trading session, IFRX stock trades at $1.81. The 52-week range is $0.74–$2.95, with a day range of $1.77–$1.86.
What is the P/E ratio for IFRX?
The P/E ratio (Price-to-Earnings) for IFRX is shown in the Key Statistics section. This valuation metric helps compare InflaRx N.V. to industry peers.
Does IFRX pay dividends?
InflaRx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IFRX?
Based on 7 analysts, the consensus for IFRX is Buy.
What is the market cap of IFRX?
InflaRx's market capitalization is $130.9M, classifying it as a micro-cap company. InflaRx operates in the Healthcare sector within the Biotechnology industry.